Litcius/Paper detail

Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study

Jiayi Wu, Jiayi Wu, Yang-Kai Fu, Xiang-Ye Ou, Shu-Qun Li, Zhi‐Bo Zhang, Jianyin Zhou, Bin Li, Shuangjia Wang, Yufeng Chen, Mao-Lin Yan

2024Annals of Surgical Oncology18 citationsDOI

Topics & Concepts

MedicineSalvage therapyHepatocellular carcinomaTranscatheter arterial chemoembolizationSurgerySurgical oncologyLenvatinibInternal medicineSalvage surgeryUrologyRadiation therapyChemotherapySorafenibHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesLiver Disease Diagnosis and Treatment
Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study | Litcius